Detailed Information

Cited 2 time in webofscience Cited 2 time in scopus
Metadata Downloads

Overexpression of poliovirus receptor is associated with poor prognosis in head and neck squamous cell carcinoma patients

Authors
Lim, Sun MinHong, Min HeeHa, Sang-JunHwang, DaeheeChae, SehyunKoh, Yoon WooChoi, Eun ChangKim, Se-HeonKim, Da-HeeYoon, Sun OchKim, Hye Ryun
Issue Date
Sep-2021
Publisher
SPRINGER
Keywords
Squamous cell carcinoma of head and neck; Biomarkers; Programmed death-ligand; Poliovirus receptor
Citation
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, v.147, no.9, pp.2741 - 2750
Journal Title
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume
147
Number
9
Start Page
2741
End Page
2750
URI
http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/300
DOI
10.1007/s00432-021-03531-8
ISSN
0171-5216
Abstract
Purpose We aimed to investigate the prognostic value of multiple immune cell markers including programmed death-ligand 1 (PD-L1) and poliovirus receptor (PVR) in head and neck squamous cell carcinoma (HNSCC) using archival tumor tissues Methods Patients diagnosed with HNSCC who have undergone surgical resection in 2005-2012 were included. Correlations between PVR and PD-L1 expression and patient characteristics were analyzed by analysis of variance. The Kaplan-Meier method and log-rank test were used to estimate survival. P values < 0.05 were considered statistically significant. Results In total, 375 primary tumor tissues were analyzed using immunohistochemistry. High PVR expression was associated with a poor prognosis in terms of overall survival (OS) and recurrence-free survival (RFS), and tumors with high PVR expression were associated with a short OS. PD-L1 tumor expression did not have a prognostic impact on survival. Univariate analysis revealed that OS and RFS were affected by age and p16 and PVR expression; multivariate analysis revealed that age and p16 and PVR expression were the most important determinants of RFS. Conclusion PVR overexpression is a poor prognostic factor in patients with HNSCC and co-targeting PVR and PD-L1 may be a promising therapeutic option that needs further investigation.
Files in This Item
There are no files associated with this item.
Appears in
Collections
연구본부 > 신경·혈관 단위체 연구그룹 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE